Search Results

Case Files

Glaucoma, Optic Disc Drusen, or Both?

Ophthalmologists discuss their diagnosis and recommendations for management.

Devesh K. Varma, MD, FRCSC; Reena Garg, MD; Paul Harasymowycz, MD; Anthony Marte, MD; Anurag Shrivastava, MD; and Nathan Radcliffe, MD

XEN^® Gel Stent: Greater Experience Leads to Greater Confidence

The XEN^® Gel Stent was initially approved for use almost 8 years ago.¹ Efficacy and safety were established in its pivotal trial.¹ Clinical experience has brought enhanced knowledge and updated techniques leading to additional perspectives on XEN^®.

Davinder Grover, MD, MPH; Lena Al-Dujaili, MD; Reena Garg, MD; and Arsham Sheybani, MD

The Literature

Advances in Therapeutics

Phase 3 clinical trials led to the FDA’s approval of a fixed-combination agent and an intracameral drug implant.

Michael Izzo, MD, and Reena A. Garg, MD

Case Files

Active Glaucoma or an Old Insult?

Clinicians discuss the diagnosis and therapeutic considerations.

Devesh K. Varma, MD, FRCSC; Reena A. Garg, MD; and Michael D. Greenwood, MD

Trauma-Induced Glaucoma

How to approach these patients.

Adam Botwinick, MD, and Reena Garg, MD

Preservative-Free Alternatives

Options for decreasing ocular toxicity in patients with glaucoma.

Arkadiy Yadgarov, MD, and Reena A. Garg, MD

Preservative-Free Alternatives

Options for decreasing ocular toxicity in patients with glaucoma.

Arkadiy Yadgarov, MD, and Reena A. Garg, MD

The Literature

The Literature

Reena A. Garg, MD, and Helen Jiang, MD

The Literature

The Literature

Reena A. Garg, MD, and Helen Jiang, MD